相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial
Mohammed Z. H. Farooqui et al.
LANCET ONCOLOGY (2015)
Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: A systematic reappraisal of classic cytogenetic data
Panagiotis Baliakas et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia
Davide Rossi et al.
BLOOD (2014)
Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption
Julio Delgado et al.
HAEMATOLOGICA (2014)
Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemia
Jane Houldsworth et al.
LEUKEMIA & LYMPHOMA (2014)
A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia
Helen E. Speedy et al.
NATURE GENETICS (2014)
Improved Detection Rate of Cytogenetic Abnormalities in Chronic Lymphocytic Leukemia and Other Mature B-Cell Neoplasms With Use of CpG-Oligonucleotide DSP30 and Interleukin 2 Stimulation
Min Shi et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2013)
Large genomic aberrations detected by SNP array are independent prognosticators of a shorter time to first treatment in chronic lymphocytic leukemia patients with normal FISH
M. Mian et al.
ANNALS OF ONCOLOGY (2013)
CCND2 rearrangements are the most frequent genetic events in cyclin D1- mantle cell lymphoma
Itziar Salaverria et al.
BLOOD (2013)
Clonal evolution in chronic lymphocytic leukemia: Analysis of correlations with IGHV mutational status, NOTCH1 mutations and clinical significance
Cristina Lopez et al.
GENES CHROMOSOMES & CANCER (2013)
NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome
N. Villamor et al.
LEUKEMIA (2013)
Sporadic and reversible chromothripsis in chronic lymphocytic leukemia revealed by longitudinal genomic analysis
L. Bassaganyas et al.
LEUKEMIA (2013)
Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?
Richard Rosenquist et al.
LEUKEMIA & LYMPHOMA (2013)
The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia
S. N. Malek
ONCOGENE (2013)
NOTCH1 mutations in CLL associated with trisomy 12
Veronica Balatti et al.
BLOOD (2012)
High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations
Jennifer Edelmann et al.
BLOOD (2012)
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia
Davide Rossi et al.
BLOOD (2012)
Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations
Tobias Rausch et al.
CELL (2012)
Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia
Jennifer R. Brown et al.
CLINICAL CANCER RESEARCH (2012)
Biallelic ATM Inactivation Significantly Reduces Survival in Patients Treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 Trial
Anna Skowronska et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia
S. J. L. Knight et al.
LEUKEMIA (2012)
Longitudinal genome-wide analysis of patients with chronic lymphocytic leukemia reveals complex evolution of clonal architecture at disease progression and at the time of relapse
E. Braggio et al.
LEUKEMIA (2012)
Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease
C. Royo et al.
LEUKEMIA (2012)
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia
S. Pospisilova et al.
LEUKEMIA (2012)
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
Victor Quesada et al.
NATURE GENETICS (2012)
Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia
Peter Ouillette et al.
BLOOD (2011)
Importance of genetics in chronic lymphocytic leukemia
Thorsten Zenz et al.
BLOOD REVIEWS (2011)
Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia
Andrea Rinaldi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia
Rebeqa Gunnarsson et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Evaluation of chronic lymphocytic leukemia by BAC-based microarray analysis
Roger A. Schultz et al.
MOLECULAR CYTOGENETICS (2011)
Evaluation of chronic lymphocytic leukemia by oligonucleotide-based microarray analysis uncovers novel aberrations not detected by FISH or cytogenetic analysis
Kathryn A. Kolquist et al.
MOLECULAR CYTOGENETICS (2011)
Deregulation of the telomerase reverse transcriptase (TERT) gene by chromosomal translocations in B-cell malignancies
Inga Nagel et al.
BLOOD (2010)
Progressive but previously untreated CLL patients with greater array CGH complexity exhibit a less durable response to chemoimmunotherapy
Neil E. Kay et al.
CANCER GENETICS AND CYTOGENETICS (2010)
Array-Based Karyotyping for Prognostic Assessment in Chronic Lymphocytic Leukemia Performance Comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 Arrays
Jill M. Hagenkord et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
M. Hallek et al.
LANCET (2010)
Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients
R. Gunnarsson et al.
LEUKEMIA (2010)
Gain of the short arm of chromosome 2 (2p) is a frequent recurring chromosome aberration in untreated chronic lymphocytic leukemia (CLL) at advanced stages
Elise Chapiro et al.
LEUKEMIA RESEARCH (2010)
The patterns and dynamics of genomic instability in metastatic pancreatic cancer
Peter J. Campbell et al.
NATURE (2010)
International network of cancer genome projects
Thomas J. Hudson et al.
NATURE (2010)
Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial
Thorsten Zenz et al.
BLOOD (2009)
Customized Oligonucleotide Array-Based Comparative Genomic Hybridization as a Clinical Assay for Genomic Profiling of Chronic Lymphocytic Leukemia
Rachel Sargent et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2009)
The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotype
F. Dicker et al.
LEUKEMIA (2009)
Atypical 11q deletions identified by array CGH may be missed by FISH panels for prognostic markers in chronic lymphocytic leukemia
S. R. Gunn et al.
LEUKEMIA (2009)
Validation of a targeted DNA microarray for the clinical evaluation of recurrent abnormalities in chronic lymphocytic leukemia
Ankita Patel et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia:: results from a detailed genetic characterization with long-term follow-up
Thorsten Zenz et al.
BLOOD (2008)
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia:: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
Michael Hallek et al.
BLOOD (2008)
Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia
Shelly R. Gunn et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2008)
Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia
Delphine Poncet et al.
BLOOD (2008)
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial
D. Catovsky et al.
LANCET (2007)
Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays
Dietmar Pfeifer et al.
BLOOD (2007)
A novel fusion of the MALT1 gene and the microtubule-associated protein 4 (MAP4) gene occurs in diffuse large B-cell lymphoma
Eva M. Murga Penas et al.
GENES CHROMOSOMES & CANCER (2006)
Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL
B Austen et al.
BLOOD (2005)
Automated array-based genomic profiling in chronic lymphocytic leukemia:: Development of a clinical tool and discovery of recurrent genomic alterations
C Schwaenen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Genomic aberrations and survival in chronic lymphocytic leukemia.
H Döhner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
